Patisiran, a RNAi therapeutic, for hereditary transthyretin amyloidosis.
Bibliographic Information
- Title
- Patisiran, a RNAi therapeutic, for hereditary transthyretin amyloidosis.
- Author
- Adams D, Gonzalez-Duarte A, O’Riordan W, Yang C, Ueda M, et al.
Journal
-
- N Engl J Med
-
N Engl J Med 印刷中 2018
- Tweet
Details 詳細情報について
-
- CRID
- 1010000781850820112
-
- Article Type
- journal article
-
- Data Source
-
- KAKEN